Sphingosine‐1‐phosphate improves outcome of no‐reflow acute myocardial infarction via sphingosine‐1‐phosphate receptor 1

Abstract Aims Therapeutic options targeting post‐ischaemic cardiac remodelling are sparse. The bioactive sphingolipid sphingosine‐1‐phosphate (S1P) reduces ischaemia/reperfusion injury. However, its impact on post‐ischaemic remodelling independently of its infarct size (IS)‐reducing effect is yet un...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Amin Polzin, Lisa Dannenberg, Marcel Benkhoff, Maike Barcik, Petra Keul, Aysel Ayhan, Sarah Weske, Samantha Ahlbrecht, Kajetan Trojovsky, Carolin Helten, Sebastian Haberkorn, Ulrich Flögel, Tobias Zeus, Tina Müller, Markus H. Gräler, Malte Kelm, Bodo Levkau
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2023-02-01
coleção:	ESC Heart Failure
Assuntos:	Cardioprotection LAD‐ligation Infarct size Remodelling Sphingosine‐1‐phosphate
Acesso em linha:	https://doi.org/10.1002/ehf2.14176
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!